3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Tuberous Sclerosis
3
Seizures
3
Sturge-Weber Syndrome
2
Tuberous Sclerosis 2
1
Tuberous Sclerosis 1
1
Spasms, Infantile
1
Lennox Gastaut Syndrome
1
Glioblastoma
1
Epilepsy
1
Epilepsies, Myoclonic
1
Drug Resistant Epilepsy
1
Cognitive Dysfunction
1
Chemotherapy-Induced Peripheral Neuropathy
1
Breast Neoplasms
1
Arthralgia
1
Anxiety Disorders
1
Interventions
Tamoxifen
9
Letrozole
5
Anastrozole
5
Radiotherapy
3
Radiation
3
Neoadjuvant Therapy
3
afimoxifene
2
Trastuzumab
2
Surgical Procedures, Operative
2
Simvastatin
2
Sentinel Lymph Node Biopsy
2
Radiation Dose Hypofractionation
2
Mastectomy, Segmental
2
Lapatinib
2
Gene Expression Profiling
2
trastuzumab biosimilar HLX02
1
telapristone acetate
1
sargramostim
1
polyphenon E
1
pasireotide
1
palbociclib
1
oxybutynin
1
liposomal doxorubicin
1
exemestane
1
Zoledronic Acid
1
UAB 30
1
Tea
1
Sugars
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Intraductal, Noninfiltrating
×
Cannabidiol
×
Clear all
No trials found.